John C. Morris

2.7k citations
43 papers · 2.1k indexed · h-index 23
Topics
Virus-based gene therapy research (12 papers)CAR-T cell therapy research (8 papers)T-cell and Retrovirus Studies (7 papers)

In The Last Decade

John C. Morris

41 papers receiving 2.0k citations

Peers

John C. Morris
Comparison fields: 5 of 115
  • Molecular Biology 827
  • Oncology 754
  • Immunology 498
  • Genetics 366
  • Psychiatry and Mental health 244
Replace Monica Rinaldi with:
Monica Rinaldi Italy
James M. Reuben United States
Tanya J. Shaw United Kingdom
Theresa V. Strong United States
Réjean Lapointe Canada
Seunghee Kim‐Schulze United States
Chia‐Ling Wu Taiwan
Barbara Power Australia
Robert A. Baiocchi United States
Sung Ho Park South Korea
John C. Morris relative to Monica Rinaldi Italy Monica Rinaldi's profile →
Citations per field
00.5×3.5×
Monica Rinaldi · 1×
Citations per year

Countries citing papers authored by John C. Morris

Since Specialization
Citations

This map shows the geographic impact of John C. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Morris more than expected).

Fields of papers citing papers by John C. Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Morris. The network helps show where John C. Morris may publish in the future.

Co-authorship network of co-authors of John C. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Morris. A scholar is included among the top collaborators of John C. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Morris. John C. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 37
3 10
4 36
5 352
6 9
7 27
8 33
9 62
10 33
11 23
12 15
13 2
14 93
15 78
16 64
17 141
18 19
19 250
20 51

About John C. Morris

John C. Morris is a scholar working on Otorhinolaryngology, Oncology and Immunology, having authored 43 papers that have together received 2.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (12 papers), CAR-T cell therapy research (8 papers) and T-cell and Retrovirus Studies (7 papers). The work is most often cited by research in Oncology (754 citations), Immunology (498 citations) and Psychiatry and Mental health (244 citations). John C. Morris has collaborated with scholars based in United States, Germany and Slovakia. Frequent co-authors include Oliver Wildner, Jay A. Berzofsky, Thomas A. Waldmann, Geoffrey I. Shapiro, Donald P. Lawrence, Bruce J. Dezube, Antoinette R. Tan, Thomas Olencki, Frank J. Hsu and John E. Janik. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026